|
University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work
|
Mon Jun 17 2013, 9:15 ET
|
|
ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21
|
Mon Jun 17 2013, 9:00 ET
|
|
Pancreatic Cancer Advocates Call on Congress to Protect Medical Research Funding From Sequestration Cuts
|
Mon Jun 17 2013, 9:00 ET
|
|
Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago
|
Mon Jun 17 2013, 9:00 ET
|
|
BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects
|
Mon Jun 17 2013, 8:48 ET
|
|
AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
|
Mon Jun 17 2013, 8:15 ET
|
|
Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company
|
Mon Jun 17 2013, 8:00 ET
|
|
Array BioPharma Announces Positive Interim Results From Combination Trial Of ARRY-520 With Kyprolis At The 2013 European Hematology Association Congress
|
Mon Jun 17 2013, 8:00 ET
|
|
Minimally Invasive Devices Adds $2.5 Million to its Series B
|
Mon Jun 17 2013, 8:00 ET
|
|
Life Technologies Expands Range of Stem Cell Reprogramming Solutions
|
Mon Jun 17 2013, 8:00 ET
|
|
Ambrx And Zhejiang Medicine Co. Ltd. Form Collaboration To Develop And Commercialize Ambrx's Antibody Drug Conjugate For Breast Cancer
|
Mon Jun 17 2013, 8:00 ET
|
|
A Big "LIKE" for Oral Hygiene
|
Mon Jun 17 2013, 8:00 ET
|
|
North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017
|
Mon Jun 17 2013, 7:45 ET
|
|
Clinical Grade RetroNectin® Reagent Available To Support Gene Therapy Clinical Research
|
Mon Jun 17 2013, 7:00 ET
|
|
Medicago Granted Patent for Influenza Virus-Like Particles in Plants
|
Mon Jun 17 2013, 7:00 ET
|
|
Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
|
Mon Jun 17 2013, 6:58 ET
|
|
PAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 26, 2013
|
Mon Jun 17 2013, 6:00 ET
|
|
Raleigh Chamber Names Bob Riedford to Board of Advisors
|
Mon Jun 17 2013, 6:00 ET
|
|
Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock
|
Mon Jun 17 2013, 6:00 ET
|
|
NGM Biopharmaceuticals and MedImmune, AstraZeneca's Biologics Arm, Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity
|
Mon Jun 17 2013, 3:00 ET
|
|
Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
|
Sun Jun 16 2013, 6:00 ET
|
|
Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions
|
Fri Jun 14 2013, 17:05 ET
|
|
Lineage Therapeutics Markets Authorized Generic Epinephrine Auto-Injector
|
Fri Jun 14 2013, 14:31 ET
|
|
Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty
|
Fri Jun 14 2013, 13:34 ET
|
|
Biozoom Exercises Purchase Option Under Joint Venture Agreement With Spectroscopic Technology Developer, Opsolution
|
Fri Jun 14 2013, 13:04 ET
|
|
Stem Cells May Help Some With Avascular Necrosis (AVN)
|
Fri Jun 14 2013, 12:49 ET
|
|
InterMune Announces Publication of Pricing and Reimbursement Conditions for Esbriet® (pirfenidone) in Italy
|
Fri Jun 14 2013, 12:38 ET
|
|
Mast Therapeutics Prices Public Offering Of Units
|
Fri Jun 14 2013, 9:24 ET
|
|
Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
|
Fri Jun 14 2013, 8:48 ET
|
|
Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding
|
Fri Jun 14 2013, 8:00 ET
|
|
Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimer's Disease
|
Thu Jun 13 2013, 16:39 ET
|
|
Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
|
Thu Jun 13 2013, 16:18 ET
|
|
PAREXEL International Appoints Ingo Bank As Senior Vice President And Chief Financial Officer
|
Thu Jun 13 2013, 16:05 ET
|
|
Cempra Provides Guidance on the Clinical Program Required for Regulatory Approval for Solithromycin for Community-Acquired Bacterial Pneumonia (CABP)
|
Thu Jun 13 2013, 16:02 ET
|
|
Cempra Announces Proposed Public Offering of Common Stock
|
Thu Jun 13 2013, 16:01 ET
|
|
FDA Approves Amgen's XGEVA® (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
|
Thu Jun 13 2013, 15:11 ET
|
|
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
|
Thu Jun 13 2013, 14:34 ET
|
|
Bluestar Silicones Presents Elastomer Solutions At Medical Design And Manufacturing (MD&M) East Show
|
Thu Jun 13 2013, 14:30 ET
|
|
Supreme Court Ruling Today Allows DNATraits to Offer Low Cost BRCA Breast and Ovarian Cancer Gene Testing in U.S.
|
Thu Jun 13 2013, 14:09 ET
|
|
RRD International Names J. Scott Tarrant President
|
Thu Jun 13 2013, 13:02 ET
|
|
IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
|
Thu Jun 13 2013, 12:53 ET
|
|
Pharmax™ Topical Creams Use Exclusive Patented Trans-dermal Delivra™ Technology from Delivra Inc.
|
Thu Jun 13 2013, 12:33 ET
|
|
Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
|
Thu Jun 13 2013, 12:13 ET
|
|
Evaluate Report to Examine Life After the Patent Cliff, Provides Analysis on Pharmaceutical and Biotech Markets and Consensus Forecasts to 2018
|
Thu Jun 13 2013, 11:00 ET
|
|
From Autism to Diabetes to Parkinson's Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
|
Thu Jun 13 2013, 10:30 ET
|
|
Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
|
Thu Jun 13 2013, 9:03 ET
|
|
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinson's Disease and Movement Disorders
|
Thu Jun 13 2013, 8:16 ET
|
|
NW Bio Has Initiated Its DCVax®-Direct Phase I/II Trial For All Solid Tumor Cancers
|
Thu Jun 13 2013, 8:15 ET
|
|
STELARA® Phase 3 Study Published In The Lancet Reports One Year Efficacy And Safety In Treatment Of Active Psoriatic Arthritis
|
Thu Jun 13 2013, 8:02 ET
|
|
Life Technologies Acquires LSK, Leading Instruments Distributor in Korea
|
Thu Jun 13 2013, 8:00 ET
|
